Replies to post #338616 on Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

GM. Thanks. Based off the info we have so far are we able to determine if the Covid dosing would be the same (or lower) as the low dosing group from that study?

The FDA didn't see any issues with this P2 trial. We had used prior studies to move past P1, so any SAEs would have been covered imho